Long-duration response to Levodopa in advanced Parkinson's disease: relevance for RCT on disease-modifying therapies. (January 2018) - Cilia, R.; Cereda, E.; Amboni, M.; Akpalu, A.; Sarfo, F.S.; Cham, M.; Fabbri, M.; Pezzoli, G.